ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 729

A Dilated Esophagus Is an Independent Risk Factor for Interstitial Lung Disease in SSc

Carrie Richardson1, Rishi Agrawal2, Jungwha Lee3, Orit Almagor4, John Varga5, Rowland W. Chang6 and Monique E. Hinchcliff7, 1Department of Medicine, McGaw Medical Center of Northwestern University, Chicago, IL, 2Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Northwestern University, Chicago, IL, 5Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 7Northwestern University, Feinberg School of Medicine, Chicago, IL

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: gastrointestinal complications, interstitial lung disease and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Session Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics: Systemic Sclerosis Measures and Outcomes

Session Type: Abstract Submissions (ACR)

Background/Purpose

High-resolution computed tomography of the chest (HRCT) performed for assessment of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) frequently reveals a patulous esophagus, but the significance is unclear. Assuming that the risk of aspiration is directly related to the magnitude of esophageal dilatation, we hypothesized that a greater HRCT esophageal diameter is associated with worse pulmonary outcomes, as measured by severity of ILD on HRCT and pulmonary function tests (PFT).

Methods

A cross-sectional study of Northwestern Scleroderma Registry patients with HRCT was conducted.  Subjects met the ACR 1980 SSc or three out of five CREST (Calcinosis cutis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasias) criteria. The esophageal diameter was measured at three levels: above the aortic arch, between the aortic arch and the right inferior pulmonary vein, and between the right inferior pulmonary vein and the diaphragmatic hiatus. Widest esophageal diameter (WED) was used as the predictor variable.  A modified Likert scale  (0= none, 1= <5%, 2= 6-25%, 3 for 26-50%, 4=51-75%, 5= >75%) was used to score fibrosis and ground glass opacities.  Total ILD (outcome variable) was calculated as the sum of fibrosis and ground glass scores.  Secondary outcomes were PFT including total lung capacity (TLC), forced vital capacity (FVC) and diffusing capacity for carbon monoxide adjusted for hemoglobin % predicted (DLCO). Standardized regression coefficients (β) between WED and the outcome variables were calculated adjusting for age, sex, ethnicity, disease subtype (limited or diffuse cutaneous SSc), disease duration (years since first non-Raynaud symptom), proton pump inhibitor use, C-reactive protein and modified Rodnan skin score.    

Results

Three hundred eleven subjects had HRCT.  Eight subjects without available HRCT images and one subject who had undergone esophagectomy were excluded.  Twenty-eight patients who had mixed connective tissue disease, SSc sine scleroderma, or overlap syndromes were excluded, leaving 275 subjects for analysis.  Adjusted standardized regressions demonstrated positive associations between WED and total ILD score (β=0.33, p<0.0001), fibrosis (β=0.32, p<0.0001), and ground glass opacities (β=0.28, p<0.0001) (Table). There were negative associations between WED and TLC % predicted (β=-0.24,p=0.0002), FVC % predicted (β=-0.23, p=0.0004), and adjusted DLCO % predicted (β=-0.23;p=0.005).

Conclusion

Increasing esophageal diameter on HRCT in patients with SSc is associated with more severe radiographic ILD, lower lung volumes, and lower DLCO % predicted.  Longitudinal studies should be done to elucidate the temporal relationship between esophageal disease and ILD in persons with SSc.  Future trials of aggressive management of esophageal disease to prevent ILD may be warranted in persons with SSc.

Table.  Association between widest esophageal diameter and HRCT findings and pulmonary function test parameters

Widest esophageal diameter (WED)

Variables

Unadjusted

β coefficient (SE)

p value

*Adjusted

β coefficient (SE)

p-value

Total ILD score

0.36 (0.07)

<0.0001

0.33 (0.08)

<0.0001

Total fibrosis score

0.32 (0.04)

<0.0001

0.32 (0.04)

<0.0001

Total ground glass score

0.32 (0.04)

<0.0001

0.28 (0.04)

<0.0001

TLC, % predicted

-0.34 (0.12)

<0.0001

-0.24 (0.13)

0.0002

FVC, % predicted

-0.31 (0.12)

<0.0001

-0.23 (0.13)

0.0004

Adjusted DLCO, % predicted

-0.29 (0.14)

<0.0001

-0.23 (0.17)

0.0005

ILD=interstitial lung disease, TLC=total lung capacity, FVC=forced vital capacity, DLCO=diffusion capacity for carbon monoxide. *Adjusted for age, sex, disease subtype, ethnicity, proton pump inhibitor use, disease duration, C-reactive protein, and modified Rodnan skin score


Disclosure:

C. Richardson,
None;

R. Agrawal,
None;

J. Lee,
None;

O. Almagor,
None;

J. Varga,
None;

R. W. Chang,
None;

M. E. Hinchcliff,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-dilated-esophagus-is-an-independent-risk-factor-for-interstitial-lung-disease-in-ssc/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies